Send us a text

From a lizard’s venom to Hollywood’s favorite weight-loss trend, this episode of Petri Dish Perspectives: Biotech Unleashed dives deep into the fascinating journey of GLP-1 agonists.

Discover how scientists uncovered a gut hormone that revolutionized diabetes care, led to the creation of Ozempic and Mounjaro, and sparked a cultural movement around body image and health. We’ll trace the science, the breakthroughs, and the billion-dollar race shaping the future of metabolic medicine.

🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

#GLP1 #Ozempic #Mounjaro #Wegovy #BiotechUnleashed #PetriDishPerspectives #Biotech #Pharma #DrugDiscovery #Obesity #Diabetes #MetabolicHealth #HealthcareInnovation #SciencePodcast

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

What if you could silence disease at its genetic root? That was the bold promise behind RNA interference (RNAi), one of the most groundbreaking scientific discoveries of the 21st century.

In this episode, we dive into the story of Alnylam Pharmaceuticals, from its founding by a powerhouse team of Nobel laureates, pioneering scientists, and biotech visionaries, to its transformation into the world’s first RNAi therapeutics company. We explore the challenges of turning a fragile lab discovery into medicine, the blockbuster drugs that redefined rare disease treatment, and the people who made it all possible.

Whether you’re a biotech enthusiast, a student of innovation, or just curious about how cutting-edge science becomes lifesaving therapy, this episode will take you inside the revolution that gave rise to RNAi medicines.

🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

#BiotechUnleashed #Alnylam #RNAi #BiotechPodcast #RareDisease #DrugDiscovery #BiotechHistory #GeneticMedicine

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.

Send us a text

From its humble beginnings in 1781 as a family-run herbal medicine shop in Osaka to becoming one of the world’s top 10 pharmaceutical companies, Takeda’s story is one of resilience, reinvention, and bold transformation.

In this episode of Petri Dish Perspectives: Biotech Unleashed, host Manead unpacks Takeda’s 240-year journey, from the vision of founder Chobei Takeda, through the blockbuster eras of Prevacid and Actos, to the game-changing acquisition of Shire under CEO Christophe Weber. We’ll dive into the discovery stories behind Takeda’s most important drugs, the leaders who left their mark, and the lessons this Japanese giant offers on balancing tradition with global ambition.

Whether you’re fascinated by pharma history, curious about blockbuster drug stories, or want to understand how one company bridged centuries of medicine, this episode has it all.

🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!

#Takeda #BiotechPodcast #PharmaHistory #DrugDiscovery #HealthcareInnovation #RareDiseases #BiotechUnleashed #PetriDishPerspectives

Support the show

© 2025 Petri Dish Perspectives LLC. All rights reserved.